person

Dimitrios B.

Country
Greece
Department
1st Oncology Department

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
268
Sites with multiple studies

Has run more than one trial at 268 of 511 partner sites.

Specializations

Melanoma Research

The investigator specializes in treating advanced and resectable melanoma, with particular focus on both early-stage and metastatic disease management. Their research encompasses adjuvant immunotherapy approaches for various stages of melanoma.

  • Stage IIB/C melanoma treatment
  • Stage III/IV melanoma management
  • Post-surgical recurrence prevention

Lung Cancer Treatment

The investigator focuses on developing treatments for various types of lung cancer, including non-small cell lung cancer (NSCLC) and small cell lung cancer. Their work includes investigating novel therapeutic combinations for advanced stages of the disease.

  • Advanced/metastatic NSCLC therapy
  • Extensive stage small cell lung cancer
  • Combined immunotherapy approaches

Breast Cancer Innovation

The investigator's work includes research on estrogen receptor-positive breast cancer and novel therapeutic approaches for HER2-negative breast cancer. Their focus extends to addressing treatment resistance in advanced cases.

  • Early-stage breast cancer treatment
  • Advanced breast cancer therapy
  • Endocrine therapy resistance

Gastrointestinal Oncology

The investigator conducts research in upper gastrointestinal tract cancers, with particular emphasis on advanced and metastatic cases. Their work includes studies on esophageal and gastric cancers.

  • Metastatic gastric cancer treatment
  • Advanced esophageal cancer therapy
  • Combined treatment approaches

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.